Skip to content
ppharmaranks
Menu
Class IICompleted

Venlafaxine Tablets recall

FDA recall D-0310-2025 · initiated Mar 21, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Apr 16, 2025How we research

Zydus Pharmaceuticals (USA) Inc recalled Venlafaxine Tablets in Mar 2025 — an FDA Class II recall (D-0310-2025) because Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: M314265, Exp.: 31 October 2025.

Quantity recalled: 13,128 100-Count Bottles

Details

Product
Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.
Recalling company
Zydus Pharms
Classification
Class II
Status
Completed
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Mar 21, 2025
FDA report date
Apr 16, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Venlafaxine Tablets recalled?
Zydus Pharmaceuticals (USA) Inc recalled Venlafaxine Tablets in Mar 2025 — an FDA Class II recall (D-0310-2025) because Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Venlafaxine Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0310-2025 was: Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Is a recalled Venlafaxine Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Venlafaxine Tablets are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot #: M314265, Exp.: 31 October 2025.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0310-2025.

Source: openFDA Drug Enforcement record D-0310-2025

← All drug recalls